Atyr Pharma Inc (LIFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 32,820 | 47,145 | 57,940 | 47,616 | 23,554 |
| Operating Income | -32,820 | -47,145 | -57,940 | -47,616 | -23,554 |
| Interest Expense | 0 | 0 | 0 | 0 | 832 |
| Other Income | -1,695 | -1,062 | 36 | -357 | 36 |
| Pre-tax Income | -34,515 | -48,207 | -57,904 | -47,973 | -24,350 |
| Income Tax | N/A | N/A | -49 | N/A | N/A |
| Net Income Continuous | -34,515 | -48,207 | -57,855 | -47,973 | -24,350 |
| Net Income | $-34,515 | $-48,207 | $-57,855 | $-47,973 | $-24,350 |
| EPS Basic Total Ops | -16.11 | -26.13 | -34.17 | -42.44 | -415.83 |
| EPS Basic Continuous Ops | -16.11 | -26.13 | -34.22 | -42.42 | -408.92 |
| EPS Diluted Total Ops | -16.11 | -26.13 | -34.17 | -42.44 | -415.83 |
| EPS Diluted Continuous Ops | -16.11 | -26.13 | -34.22 | -42.42 | -408.92 |
| EPS Diluted Before Non-Recurring Items | -16.11 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-31,369 | $-45,828 | $-56,336 | $-44,250 | $-22,256 |